Ryan Phillips

Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERI...

PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like...

Salvage RT plus enzalutamide of placebo bij hoogrisico prostaatcarcinoom: SALV-ENZA fase II

Observatie versus SABR bij oligometastatisch prostaatcarcinoom: ORIOLE fase II